KTRA - Kintara Therapeutics Inc
IEX Last Trade
0.1873
-0.002 -0.961%
Share volume: 1,177,884
Last Updated: Fri 30 Aug 2024 09:58:10 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.19
0.00
-0.95%
Fundamental analysis
22%
Profitability
25%
Dept financing
9%
Liquidity
50%
Performance
15%
Performance
5 Days
-17.13%
1 Month
-16.58%
3 Months
-41.10%
6 Months
84.30%
1 Year
-95.99%
2 Year
-97.59%
Key data
Stock price
$0.19
DAY RANGE
$0.18 - N/A
52 WEEK RANGE
$0.08 - $4.92
52 WEEK CHANGE
-$0.96
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Saiid Zarrabian
Region: US
Website: https://www.kintara.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.kintara.com/
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Recent news